ARTICLE | Analyst Picks & Changes
Analyst picks & changes
July 6, 1993 7:00 AM UTC
Timothy Wilson of Hambrecht & Quist initiated coverage with a 'buy" rating. By biotechnology standards, the company is low risk, with one product on the market ( ...
Timothy Wilson of Hambrecht & Quist initiated coverage with a 'buy" rating. By biotechnology standards, the company is low risk, with one product on the market ( ...